CLX — Clorox Company (The)

Is CLX overbought or oversold? Here is the current MarketMoodz read.

Consumer Defensive · Household & Personal Products

Overbought As of August 19, 2026

Clorox Company (The) (CLX) currently reads Overbought on the MarketMoodz overbought/oversold meter, as of August 19, 2026. The Consumer Defensive name (Household & Personal Products) last closed at $107.90. The rating moved from Neutral to Overbought on August 19, 2026.

See all overbought Consumer Defensive stocks →

AI analysis

Clorox Company (The) (CLX) remains a cash-generative, defensive consumer staples business with entrenched brands in cleaning and household categories. Financial health is supported by steady revenue, margin management initiatives and a commitment to shareholder distributions, though organic growth is modest and dependent on pricing, product innovation, and cost-out programs. Competitive pressure from private-label offerings and the cost of reformulating products to meet clean-label trends are the principal near-term headwinds. Market perception appears steady with defensive sector interest and no major macro or geopolitical shocks in the recent window. Near-term performance will hinge on execution of productivity measures, ability to sustain pricing without eroding volume, and progress on margin recovery; outcomes range from stable cash returns and gradual improvement to margin compression if input costs or competitive pressures intensify.

Key factors

  • Strong, defensive brand portfolio in household and cleaning products with durable shelf presence and pricing power
  • Stable cash flow generation and a history of returning capital to shareholders via dividends and buybacks
  • Exposure to input-cost volatility (commodities, packaging) but demonstrated ability to pass through some inflation to consumers
  • Moderate organic growth profile with emphasis on productivity, mix improvement, and occasional portfolio optimization
  • Regulatory and consumer trends toward clean-label ingredients that create both reformulation costs and premiumization opportunities
  • Relative resilience in economic slowdowns as a consumer staples name, limiting downside in risk-off market environments

Risks

  • Sustained commodity or freight inflation that compresses margins if pricing pass-through lags
  • Intense private-label competition and promotional pressure from large retailers compressing volumes and share
  • Execution risk on reformulation initiatives (costs, supply constraints, slower consumer adoption)
  • Concentration in retail customers and channel mix shifts that could pressure revenue if major accounts push for lower prices
  • Currency and macro risks in international markets that can impact reported results
  • Limited near-term growth catalysts beyond cost savings and pricing, raising investor sensitivity to any earnings miss

Latest MarketMoodz coverage

See today's live rating, score and targets

Members see the live hourly rating for CLX — the numeric AI score plus targets and entry zones — while this public page updates nightly.

Start the 14-day trial

This page is for informational purposes only and is not investment, financial, tax, or legal advice. Ratings and research outputs can be wrong, incomplete, or stale. Past performance does not guarantee future results. Always do your own research and consider consulting a qualified professional.